APA
Viúdez A., Carmona-Bayonas A., Gallego J., Lacalle A., Hernández R., Cano J. M., Macías I., Custodio A., Martínez de Castro E., Sánchez A., Iglesia L., Reguera P., Visa L., Azkarate A., Sánchez-Cánovas M., Mangas M., Limón M. L., Martínez-Torrón A., Asensio E., Ramchandani A., Martín-Carnicero A., Hurtado A., Cerdà P., Garrido M., Sánchez-Bayonas R., Serrano R. & Jiménez-Fonseca P. (20201223). Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
Chicago
Viúdez A, Carmona-Bayonas A, Gallego J, Lacalle A, Hernández R, Cano J M, Macías I, Custodio A, Martínez de Castro E, Sánchez A, Iglesia L, Reguera P, Visa L, Azkarate A, Sánchez-Cánovas M, Mangas M, Limón M L, Martínez-Torrón A, Asensio E, Ramchandani A, Martín-Carnicero A, Hurtado A, Cerdà P, Garrido M, Sánchez-Bayonas R, Serrano R and Jiménez-Fonseca P. 20201223. Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
Harvard
Viúdez A., Carmona-Bayonas A., Gallego J., Lacalle A., Hernández R., Cano J. M., Macías I., Custodio A., Martínez de Castro E., Sánchez A., Iglesia L., Reguera P., Visa L., Azkarate A., Sánchez-Cánovas M., Mangas M., Limón M. L., Martínez-Torrón A., Asensio E., Ramchandani A., Martín-Carnicero A., Hurtado A., Cerdà P., Garrido M., Sánchez-Bayonas R., Serrano R. and Jiménez-Fonseca P. (20201223). Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
MLA
Viúdez A, Carmona-Bayonas A, Gallego J, Lacalle A, Hernández R, Cano J M, Macías I, Custodio A, Martínez de Castro E, Sánchez A, Iglesia L, Reguera P, Visa L, Azkarate A, Sánchez-Cánovas M, Mangas M, Limón M L, Martínez-Torrón A, Asensio E, Ramchandani A, Martín-Carnicero A, Hurtado A, Cerdà P, Garrido M, Sánchez-Bayonas R, Serrano R and Jiménez-Fonseca P. Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20201223.